AbbVie Inc.

10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Results of operations (earnings release) Jul 31, 2026 8-K Results of operations (earnings release) Jul 6, 2026 8-K Regulation FD disclosure Jun 22, 2026 8-K Shareholder vote results May 12, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Results of operations (earnings release) Apr 29, 2026 8-K Results of operations (earnings release) Apr 3, 2026 8-K Other events Mar 4, 2026 8-K Other events Feb 26, 2026 10-K Fiscal year ended 2025-12-31 Feb 20, 2026 8-K Results of operations (earnings release) Feb 4, 2026 8-K Results of operations (earnings release) Jan 7, 2026 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Oct 31, 2025 8-K Results of operations (earnings release) Oct 3, 2025 8-K Regulation FD disclosure Sep 11, 2025 10-Q Quarter ended 2025-06-30 Aug 4, 2025 8-K Results of operations (earnings release) Jul 31, 2025 8-K Results of operations (earnings release) Jul 3, 2025 8-K Director or officer change; Shareholder vote results May 13, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release) Apr 25, 2025 8-K Results of operations (earnings release) Apr 3, 2025 8-K Other events Feb 26, 2025 8-K Other events Feb 19, 2025 10-K Fiscal year ended 2024-12-31 Feb 14, 2025 8-K Director or officer change; Regulation FD disclosure Feb 14, 2025 8-K Other events Feb 5, 2025 8-K Results of operations (earnings release) Jan 31, 2025 8-K Material impairment Jan 10, 2025 8-K Results of operations (earnings release) Jan 6, 2025 8-K Director or officer change Dec 13, 2024 10-Q Quarter ended 2024-09-30 Nov 4, 2024 8-K Results of operations (earnings release) Oct 30, 2024 8-K Results of operations (earnings release) Oct 3, 2024 8-K Amended charter or bylaws Sep 10, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Jul 25, 2024 8-K Results of operations (earnings release) Jul 3, 2024